IGF-1 LR3 1mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview IGF-1 LR3 is a long-acting insulin-like growth factor analogue frequently evaluated within biochemical and cellular-modelling research for its relevance to growth-factor signalling, receptor interaction and tissue-development pathways. This lyophilized 1 mg peptide enables controlled laboratory evaluation of purity stability and mechanistic behaviour.   Peptide Overview Between 2010 and 2025 IGF-1 LR3 has been widely examined for its extended half-life properties, increased receptor-binding potential and biochemical relevance to IGF/insulin-pathway modelling. Its stability and well-defined analytical profile support reproducible in-vitro research conditions.   Historical Background and Scientific Context Research on IGF-related pathways expanded significantly from 2014 onward as laboratories sought to better understand cell-growth signalling, tissue-development mechanisms and metabolic-regulation models. IGF-1 LR3 remains a central compound for studying long-acting analogues with modified receptor affinity and enhanced biochemical signalling.   Mechanistic Focus in Research

• Growth-factor signalling-pathway modelling
• In-vitro receptor interaction and response evaluation
• Comparative structural analysis of IGF-class analogues
• Cell-development and metabolic-regulation studies
• Biochemical modelling in controlled laboratory environments

  Analytical Verification (COA) Independent Liquilabs analysis confirms analytical validation for Batch GF092025032. Key results include:

• Assay Content: 1.076 mg
• Identification – Retention Time: 0.990
• Identification – Spectrum: 984
• Purity: above 99.8 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury vanadium

All analytical values were obtained using validated chromatographic spectroscopic and microbiological procedures ensuring complete traceability.   Research Applications

• IGF-pathway biochemical modelling
• Cell-growth and receptor-interaction studies
• Comparative evaluation of long-acting IGF analogues
• In-vitro metabolic-regulation modelling
• Controlled biochemical experimentation

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF092025032 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.